Back to funds
View filing
Sarissa Capital Management LP
hedge fundUpdated 28 days agoManaged by Sarissa Capital Management Lp • Latest filing Q2 2026
Portfolio value
$177.9M
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
-41.4%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $781.9M |
| Q2 2023 | $1B |
| Q3 2023 | $742.4M |
| Q4 2023 | $648.9M |
| Q1 2024 | $571.6M |
| Q2 2024 | $592.4M |
| Q3 2024 | $402.3M |
| Q4 2024 | $322.9M |
| Q1 2025 | $154.7M |
| Q2 2025 | $154.4M |
| Q3 2025 | $180.4M |
| Q4 2025 | $222.9M |
| Q1 2026 | $157.6M |
| Q2 2026 | $177.9M |
Top holdings
10 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | I INVA INNOVIVA INC | $42.9M | 1.89M | 24.14% | — |
| 2 | I IRWD IRONWOOD PHARMACEUTICALS INC | $38.7M | 9.19M | 21.75% | — |
| 3 | A AMRN AMARIN CORP PLC | $26.7M | 1.67M | 15.00% | — |
| 4 | N NBIX NEUROCRINE BIOSCIENCES INC | $19.6M | 116.5K | 11.04% | — |
| 5 | C CYTK CYTOKINETICS INC | $19.5M | 228.6K | 10.95% | — |
| 6 | L LNTH LANTHEUS HLDGS INC | $18.5M | 166.9K | 10.41% | — |
| 7 | B BHVN BIOHAVEN LTD | $8.7M | 582.3K | 4.87% | — |
| 8 | R REGN REGENERON PHARMACEUTICALS | $2.6M | 4.2K | 1.47% | — |
| 9 | V VOR VOR BIOPHARMA INC | $468K | 25.4K | 0.26% | — |
| 10 | B BIIB BIOGEN INC | $205K | 950 | 0.12% | — |